Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DM

David Moebius — 12 Patents

OTOnyx Therapeutics: 5 patents #11 of 49Top 25%
AMAmgen: 5 patents #659 of 2,867Top 25%
CYCytokinetics: 4 patents #58 of 199Top 30%
Harvard University: 1 patents #1,740 of 3,600Top 50%
SPSyros Pharmaceuticals: 1 patents #39 of 53Top 75%
Foster City, CA: #330 of 2,058 inventorsTop 20%
California: #51,404 of 386,348 inventorsTop 15%
Overall (All Time): #396,045 of 4,157,543Top 10%
12 Patents All Time
David Moebius has been granted 12 US patents while listed as an inventor at Amgen. The first was granted in 2016 and the most recent in October 2023. David Moebius ranks #396,045 of 4,157,543 US inventors in our database (top 9.5%). Patent records list David Moebius in Foster City, CA, US.

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11780826 Bisamide sarcomere activating compounds and uses thereof Luke W. Ashcraft, Alessandro Boezio, John R. BUTLER, Aroop Chandra, Chihyuan Chuang +15 more 2023-10-10 $456,665,000
11299479 Bisamide sarcomere activating compounds and uses thereof Luke W. Ashcraft, Alessandro Boezio, John R. BUTLER, Aroop Chandra, Chihyuan Chuang +15 more 2022-04-12 $52,235,000
11078233 Tripeptide epoxy ketone protease inhibitors Dustin McMinn, Henry Johnson, Simeon Bowers 2021-08-03
11040981 Pyrrolotriazine compounds and methods of inhibiting TAM kinases Jason J. Marineau, Yi Zhang, Claudio Edmundo Chuaqui, Goran Malojcic, William Sinko +6 more 2021-06-22 $6,771,000
10899746 Bisamide sarcomere activating compounds and uses thereof Luke W. Ashcraft, Alessandro Boezio, John R. BUTLER, Aroop Chandra, Chihyuan Chuang +15 more 2021-01-26 $988,568,000
10723720 Bisamide sarcomere activating compounds and uses therof Luke W. Ashcraft, Alessandro Boezio, John R. BUTLER, Aroop Chandra, Chihyuan Chuang +15 more 2020-07-28 $474,265,000
10689367 Triazole pyridyl compounds as agonists of the APJ receptor Yinhong Chen, Alan C. Cheng, Mikkel V. Debenedetto, Paul John Dransfield, James S. Harvey +8 more 2020-06-23 $918,346,000
10647744 Tripeptide epoxy ketone protease inhibitors Dustin McMinn, Henry Johnson, Simeon Bowers 2020-05-12
RE47302 Peptide epoxyketone immunoproteasome inhibitors Dustin McMinn, Henry Johnson, Simeon Bowers 2019-03-19
9657057 Dipeptide and tripeptide epoxy ketone protease inhibitors Dustin McMinn, Henry Johnson 2017-05-23
9434761 Tripeptide epoxy ketone protease inhibitors Dustin McMinn, Henry Johnson, Simeon Bowers 2016-09-06
9321713 Hyperforin analogs, methods of synthesis, and uses thereof Matthew D. Shair, Brian Andrew Sparling 2016-04-26